Xtandi - Xpensive - Xtortion !

Xtandi the new drug for the treatment of advanced prostate cancer has been launched at the extortionate price of $ 7,450 per month. This is exacting a high price from desperate people with prostate cance who may not be covered by medical insurance. How can anyone afford this treatment ? A lot of prostate cancer sufferers have keenly watched the progress of MDV3100 through clinical trials over a number of years each time waiting for the next results on this drug. Having finally gained FDA approval a lot of prostate cancer sufferers feel let down by the very high price for this medication. The price of Xtandi needs to be set lower than that of Zytiga in order to compete with it.